QVITI develops non-invasive neuromodulation hardware and software for neurorehabilitation and clinical research. The company positions its systems around transcranial electrical stimulation and supervised therapy delivery.

Its platform combines programmable tES stimulation with software modules that can incorporate immersive VR/AR (XR) experiences and protocol configuration. The product line includes a research-oriented tES system supporting multiple stimulation modes and integration into lab setups.

Target use cases include post-stroke rehabilitation (motor and language), aphasia therapy support, and other neuropsychiatric and cognitive indications where stimulation is used alongside structured rehabilitation. Deployment is positioned for clinician-supervised settings and research centers, with integration into existing clinical or experimental workflows.